Moreover, other studies have shown that the synthesis and/or release of nitric oxide in arterial hypertension is normal, but its bioavailability is reduced due to increased superoxide anion production, mainly by increasing NADPH oxidase activity, which inactivates nitric oxide generating nitrite peroxide [35]–[37]. This evidence concerns the gene FMO5 and Hypertension.